TRANSCRIPTIONAL REGULATION OF BASIC FIBROBLAST GROWTH-FACTOR GENE BY P53 IN HUMAN GLIOBLASTOMA AND HEPATOCELLULAR-CARCINOMA CELLS

被引:138
作者
UEBA, T
NOSAKA, T
TAKAHASHI, JA
SHIBATA, F
FLORKIEWICZ, RZ
VOGELSTEIN, B
ODA, Y
KIKUCHI, H
HATANAKA, M
机构
[1] KYOTO UNIV, INST VIRUS RES, KYOTO 606, JAPAN
[2] KYOTO UNIV, FAC MED, DEPT NEUROSURG, KYOTO 606, JAPAN
[3] TOYAMA MED & PHARMACEUT UNIV, FAC PHARMACEUT SCI, TOYAMA 93010, JAPAN
[4] WHITTIER INST DIABET & ENDOCRINOL, DEPT BIOCHEM, LA JOLLA, CA 92037 USA
[5] WHITTIER INST DIABET & ENDOCRINOL, DEPT MOLEC & CELLULAR GROWTH BIOL, LA JOLLA, CA 92037 USA
[6] JOHNS HOPKINS UNIV, SCH MED, DEPT ONCOL, BALTIMORE, MD 21231 USA
关键词
MUTANT P53; TUMOR PROGRESSION; BRAIN TUMOR;
D O I
10.1073/pnas.91.19.9009
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mutations of the p53 gene are found in various human cancers. The frequency of its mutation is reported to increase during tumor progression in most tumors. In human gliomas, mutations of the p53 gene are found in about one-third of the malignant forms and in few of the benign ones, indicating their possible involvement in tumor progression. On the other hand, we have recently shown that basic fibroblast growth factor (basic FGF) plays a crucial role in tumor progression as an autocrine growth factor in tissues of human gliomas. Therefore, we hypothesized that p53 might regulate the promoter activity of the basic FGF gene, which has several GC boxes and no typical TATA box. In this study, cotransfection assays using human glioblastoma and hepatocellular carcinoma cells and establishment of stable cell lines expressing mutant-type p53 were performed. The basic FGF gene pro meter was demonstrated to be regulated by p53 at the transcriptional level and its basal core promoter was found to be responsive to p53. Expression of endogenous basic FGF was also demonstrated to be activated by mutant type p53. Wildtype p53 repressed gene expression of the basic FGF and its mutant activated it in vitro, implying one of the possible pathways in tumor progression.
引用
收藏
页码:9009 / 9013
页数:5
相关论文
共 53 条
[21]   A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA [J].
KASTAN, MB ;
ZHAN, QM ;
ELDEIRY, WS ;
CARRIER, F ;
JACKS, T ;
WALSH, WV ;
PLUNKETT, BS ;
VOGELSTEIN, B ;
FORNACE, AJ .
CELL, 1992, 71 (04) :587-597
[22]   HUMAN-TUMOR CELLS SYNTHESIZE AN ENDOTHELIAL-CELL GROWTH-FACTOR THAT IS STRUCTURALLY RELATED TO BASIC FIBROBLAST GROWTH-FACTOR [J].
KLAGSBRUN, M ;
SASSE, J ;
SULLIVAN, R ;
SMITH, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2448-2452
[23]   HUMAN PAPILLOMAVIRUS E6 PROTEINS BIND P53 INVIVO AND ABROGATE P53-MEDIATED REPRESSION OF TRANSCRIPTION [J].
LECHNER, MS ;
MACK, DH ;
FINICLE, AB ;
CROOK, T ;
VOUSDEN, KH ;
LAIMINS, LA .
EMBO JOURNAL, 1992, 11 (08) :3045-3052
[24]   THE P53 TUMOR SUPPRESSOR GENE [J].
LEVINE, AJ ;
MOMAND, J ;
FINLAY, CA .
NATURE, 1991, 351 (6326) :453-456
[25]   ALTERED CELL-CYCLE ARREST AND GENE AMPLIFICATION POTENTIAL ACCOMPANY LOSS OF WILD-TYPE P53 [J].
LIVINGSTONE, LR ;
WHITE, A ;
SPROUSE, J ;
LIVANOS, E ;
JACKS, T ;
TISTY, TD .
CELL, 1992, 70 (06) :923-935
[26]  
LOBB R, 1986, J BIOL CHEM, V261, P1924
[27]   SPECIFIC REPRESSION OF TATA-MEDIATED BUT NOT INITIATOR-MEDIATED TRANSCRIPTION BY WILD-TYPE-P53 [J].
MACK, DH ;
VARTIKAR, J ;
PIPAS, JM ;
LAIMINS, LA .
NATURE, 1993, 363 (6426) :281-283
[28]  
MARTIN DW, 1993, J BIOL CHEM, V268, P13062
[29]   REARRANGEMENT OF THE P53 GENE IN HUMAN OSTEOGENIC SARCOMAS [J].
MASUDA, H ;
MILLER, C ;
KOEFFLER, HP ;
BATTIFORA, H ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7716-7719
[30]   EXPRESSION OF HUMAN BASIC FIBROBLAST GROWTH-FACTOR CDNA IN BABY HAMSTER-KIDNEY DERIVED CELLS RESULTS IN AUTONOMOUS CELL-GROWTH [J].
NEUFELD, G ;
MITCHELL, R ;
PONTE, P ;
GOSPODAROWICZ, D .
JOURNAL OF CELL BIOLOGY, 1988, 106 (04) :1385-1394